Omer Ziv

Omer Ziv has a diverse and extensive work experience in the field of molecular biology and research. Omer is currently working as the Director of RNA Biology at Eleven Therapeutics since June 2021. Prior to this role, they served as a Senior Research Associate and Research Fellow at the University of Cambridge from November 2020 to June 2021. At the university, their work primarily focused on studying RNA viruses, such as the Zika virus, and developing new tools to probe their genomic structure and interactions with host RNAs.

Before their time at the University of Cambridge, Omer was a PhD student at the Weizmann Institute of Science from April 2008 to 2013. During their PhD, they investigated the molecular mechanism behind high mutation rates and cancer predisposition in individuals with Xeroderma Pigmentosum Variant disease. Omer also developed a method to identify new players in mutagenic DNA damage tolerance pathways and discovered a link between these pathways and the severity of Acute Myeloid Leukemia (AML).

Prior to their PhD, Omer worked as an MSc student at the Weizmann Institute of Science from 2005 to 2008. Omer also gained research experience as a Research Assistant at the Technion - Israel Institute of Technology from 2004 to 2005.

Overall, Omer Ziv's work experience showcases their expertise in RNA biology, virus research, and molecular mechanisms behind cancer predisposition.

Omer Ziv's education history begins with a Bachelor of Science degree in Biology, General, which was obtained from the Technion - Israel Institute of Technology between 2002 and 2005. Following this, Ziv pursued a Master of Science degree at the Weizmann Institute of Science, specializing in DNA repair, from 2005 to 2008. Continuing their academic journey, Ziv obtained a Doctor of Philosophy (PhD) in Molecular Biology from the same institution, the Weizmann Institute of Science, from 2008 to 2013. Lastly, Ziv pursued a postdoctoral fellowship at the University of Cambridge from 2013 to 2021, where their field of study was RNA Biology.